Centrillion is creating transformative genomic technologies leveraging engineering and biochemistry breakthroughs to accelerate discovery and reveal the real genome that has thus far been obscured by its complexity and the limitations of existing technologies. Our team of scientists and engineers is committed to making a new generation of genomic technologies accessible and affordable for a multitude of previously unapproachable apps.
Centrillion is backed by venture capital and strategic investors and is located at Palo Alto, CA, at the innovation center of Silicon Valley and close to Stanford University.
